866-503-0857
1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)Drug: Cerdelga™ (eliglustat) Cerezyme® (imiglucerase) Elelyso™ (taliglucerase alfa) Vpriv™ (velaglucerase alfa) Zavesca® (miglustat) Note: Precertification review for all medications except Cerdelga are handled through Aetna Specialty Precert Unit at 1-866-503-0857
Did you know?
1-866-503-0857 . For other lines of business: Please use other form . Note: Procrit and Epogen are non-preferred. The preferred products are Aranesp and Retacrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-503-0857 . For other lines of business: Please use other form. Note: Xgeva is non-preferred. The preferred products are pamidronate or zoledronic acid. Pamidronate and zoledronic acid do not require precertification. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date:PHONE: 1-866-503-0857 For other lines of business: Please use other form. Note: Granix is non preferred. Zarxio is preferred. Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.Aetna Precertification Notification 503 Sunport Lane Orlando FL 32809 Phone 1-866-503-0857 FAX 1-888-267-3277 Injectable Medication Precertification Request Please indicate Start of treatment Ship to Doctor s office Patient Continuation of therapy Date needed Phone Dispensing Provider Today s date Other Aetna Specialty Pharmacy or Fax TIN PIN A. DIAGNOSIS INFORMATION Primary ICD-9 170. 0-170 ...Phone: 1-866-503-0857 (TTY:711) VPRIV ® (velaglucerase alfa) FAX: 1-844-268-7263 . For other lines of business: Medication Precertification Request. Please use other form. Page 2 of 2 Note: Vpriv is non-preferred. The (All fields must be completed and legible for Precertification Review.) preferred products are Cerezyme and Elelyso. Patient ...Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service for Remicade, see Utilization Management Policy on Site of Care for Specialty Drug Infusions at https://www.aetna ...June 30, 2023. Many scams start with an intimidating phone call. A “debt collector” needs you to pay immediately. Or a “police officer” claims to have a warrant for your arrest. The latest ...Phone: 1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 For Medicare Advantage Part B: Page 2 of 2 Phone: 1-866-503-0857 (All fields must be completed and legible for precertification review) FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . H. ACKNOWLEDGEMENT Request Completed ByNote: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Fulphila, Granix, Leukine, Neulasta, Neupogen, Nivestym, Udenyca and Zarxio are subject to precertification. If ...PHONE: 1-866-503-0857 For other lines of business: please use other form. Note: Nivestym is non preferred. Zarxio is preferred. Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.1-866-503-0857 . For other lines of business: Please use other form . Note: Procrit and Epogen are non-preferred. The preferred products are Aranesp and Retacrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /If you are not the intended recipient, you are notified that any use, distribution or copying of the attached material is strictly prohibited and may subject you to criminal or civil penalties. If you received this transmission in error, please notify us immediately by telephone at (866) 503-0857. GR-69377 (5-18)1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Susvimo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. Precertification Requested By:1-866-503-0857 . For other lines of business: Please use other form. Note: Xgeva is non-preferred. The preferred products are pamidronate or zoledronic acid. Pamidronate and zoledronic acid do not require precertification. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date:Precertification Request Aetna Precertification Notification . Phone: 1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last ...1-866-503-0857 . For other lines of business: Please use other form. Note: Stelara is non-preferred. Preferred products vary based on indication. See section G below. (Please return. Pages 1 to 3. for precertification of medications.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment ...For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lucentis and Cimerli are non- preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require ...Alirocumab (PraluentTM) Injectable Medication Precertification Request. Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857. Page 1 of 2. FAX: 1-888-267-3277. (All fields must be completed and legible for precertification review) For Medicare Advantage Part B: FAX: 1-844-268-7263.Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Lanreotide (Cipla) is non-preferred. The preferred products are Sandostatin LAR and Page 1 of 2 Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment:Start dateFor Medicare Advantage Part B: FAX: PHONE: 1-844-268-7263 1-866-503-0857. For other lines of business: please use other form. Note: Neulasta is non preferred. Udenyca is preferred. Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION.1-866-503-0857 . For other lines of business: Please use other form . Note: Epogen and Retacrit are non-preferred. The preferred products are Aranesp and Procrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentAetna Recertification Notification 503 Support Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 Viscosupplementation Injectable Medication Recertification Request Please indicate: ... 1-866-503-0857 FAX: 1-888-267-3277 Viscosupplementation Injectable Medication Recertification Request Please indicate: We are not affiliated with ...
866-503-1875 [email protected] Contact Us; Login; Accurate, instant vehicle reports. Create Report. Make. $1 for one report (limited use) $29.95/mo for 3 months of 30 reports/mo. Why do I need a report? ONLINEDATALOOKUP.COM. Simple Sales LLC 13320 S. Mackinaw Avenue, Chicago, Illinois 60633Who is calling or texting from 866-503-0857 phone number? Reverse Phone Lookup registered owner's full name, address, public records & background check for +1 866 …Phone: 1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 / / Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Penile cancer. Yes . NoPhone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment.Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Benlysta is subject to precertification. If precertification requirements apply Aetna considers Benlysta to be medically necessary for those members who meet ALL of the following precertification criteria:
1-866-503-0857 . For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. Page 1 of 3 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, last ...Synagis™ (palivizumab ) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Refer to Medical CPB #0318 Synagis (Palivizumab) Policy: Precertification Criteria. Under some plans, including plans that use an open or closed formulary, Synagis is subject to precertification.PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Eylea and Eylea HD are non-preferred. The preferred product is bevacizumab (Avastin). Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. (All fields must be completed and legible for precertification review.)…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-752-7021 Kadcyl. Possible cause: 1-866-503-0857 . For other lines of business: Please use other form. Note: Orencia.
1-866-503-0857. For other lines of business: Please use other form. Note: Granix, Leukine, Neupogen, Nivestym, and Releuko are non-preferred. Zarxio is preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentPolicy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Intravenous Immunoglobulins (IVIG) and Adagen are subject to Precertification. If Precertification requirements apply Aetna considers these medications to be medically necessary for those members who meet the following precertification criteria: (see also Appendix A)1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 2 of 2 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)
1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...Note: Precertification review for Nplate is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Nplate is subject to precertification. If precertification requirements apply, Aetna considers this medication to be medically ...1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy,Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...
Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 . For other l • Call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277<br /> 17. Special programs<br /> Beginning Right ® maternity program<br /> ... • Call 1-866-782-2779 for information on injectable medications not listed<br /> • Visit Clinical Policy Bulletins and DocFind ®<br />For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263. G. CLINICAL INFORMATION (continued) - - Required clinical information must be completed in its entirety for all precertification requests. Yes No Was the patient prescribed the requested drug due to clinical worsening after receiving gene replacement therapy (e.g ... PHONE: 1-866-503-0857 . For other lines of business: Please use othePHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Ple 503 Sunport Lane, Orlando, FL 32809 . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review) Please indicate: Start of treatment: Start date: / / Continuation of therapy: Date of last treatment / /+1 866-602-0857 (Toll-free, United States) This number 8666020857 has received 1 user comment and has been searched 28 times. Last time user left a comment was 15 Jan 2024 and it was last time checked by visitors 3 months ago 🕑.. This number appears to be Toll-free operating in United States. A toll-free number is a phone number that callers can use to reach a business or person without ... Please indicate: Start of treatment: Start date / / Continuation of th Phone: 1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 1 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name . Patient Last Name . Patient Phone . Patient DOB 1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . F1-866-503-0857 . For other lines of business: PPlease indicate: Start of treatment: Star 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION - Required clinical information must be completed in its entirety for all precertification requests. PHONE: 1-866-503-0857 . For other lines of Aetna Precertification Notification 503 Sunport Lane Orlando FL 32809 Phone 1-866-503-0857 FAX 1-888-267-3277 Injectable Medication Precertification Request Please indicate Start of treatment Ship to Doctor s office Patient Continuation of therapy Date needed Phone Dispensing Provider Today s date Other Aetna Specialty Pharmacy or Fax TIN PIN A. DIAGNOSIS INFORMATION Primary ICD-9 170. 0-170 ... Right knee. Left knee. Aetna Precertification Notification 503 Sunp[Phone: 1-866-752-7021 . FAX: 1-888-267-32771-866-752-7021 Medication Precertification To initiate precertification or inquire about pending precertification, call an Aetna representative toll free at 1-866-503-0857. Next-day delivery Complete orders received before 3 p.m. ET are scheduled for next-day delivery. RefillsBrentuximab vedotin Injectable Medication Precertification Request Aetna Precertification Notification 503 Sunport Lane Orlando FL 32809 Phone 1-866-503-0857 FAX 1-888-267-3277 All fields must be completed and legible for precertification review Please indicate Start of treatment Start date / Continuation of therapy Date of last treatment.